MapLight Therapeutics (MPLT) Times Interest Earned (2024 - 2026)

MapLight Therapeutics (MPLT) posted Times Interest Earned of -$277.92 for Q4 2025, down 3535.29% sequentially from -$7.65 in Q3 2025, and down 466.06% YoY from $75.92 in Q4 2024.

MapLight Therapeutics (MPLT) Times Interest Earned (2024 - 2026) Analysis & Trends

MapLight Therapeutics has reported Times Interest Earned for 2 years, with the latest figure at -$277.92 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 2.84
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 24.64
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -0.19
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 8.18
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -0.01
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.61
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2.82
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.08
10 MapLight Therapeutics 533.88 Mn 533.88 Mn - -0.70

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.70
Dec 31, 2025 -277.92
Sep 30, 2025 -7.65
Dec 31, 2024 75.92
Sep 30, 2024 -69.65